Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study.

Gaurav Syal,Daniel S Mishkin,Andrea Banty,Susie Lee, Norma Fontelera,Melissa Hampton,David Ziring,Phillip R Fleshner,Gil Y Melmed

Inflammatory bowel diseases（2023）

引用 0|浏览1

暂无评分

摘要

Oral tofacitinib can be effective in inducing response and remission in patients with chronic antibiotic refractory pouchitis. In addition to improving symptoms and quality of life, it can lead to improvement in endoscopic inflammation score and fecal calprotectin.

查看译文

关键词

chronic pouchitis, tofacitinib, modified pouch disease activity index, calprotectin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要